Measurement of changes in sarcoplasmic reticulum [Ca2+] in rat tail artery with targeted apoaequorin delivered by an adenoviral vector.
The physiologic relevance of Ca2+ release from the sarcoplasmic reticulum in arterial smooth muscle contraction is controversial. Therefore, we sought to measure changes in sarcoplasmic reticulum free [Ca2+] (i.e. [Ca2+]sr) in the intact rat tail artery. We exploited a novel technique to measure [Ca2+]sr with genetically targeted apoaequorin acting as a pseudo-luciferase rather than as classic aequorin. Intact rat tail arteries were infected with a replication deficient adenoviral vector (RAdER) containing the apoaequorin gene targeted to the sarcoplasmic reticulum. Addition of apoaequorin's substrate, coelenterazine, to the perfusate increased light production in a [Ca2+] dependent manner, consistent with apoaequorin action on coelenterazine. Within the limits of the photon counting system, imaging of infected rat tail artery segments revealed light production from the whole thickness of the vascular wall. Phenylephrine stimulation decreased apoaequorin generated light and induced a contraction. Washout of phenylephrine relaxed the tissues and increased light indicating refilling of the sarcoplasmic reticulum with Ca2+. Incubation in 10 microM cyclopiazonic acid, a SERCA inhibitor, did not alter apoaequorin generated light or induce a contraction. In the presence of cyclopiazonic acid, phenylephrine contractions were enhanced and apoaequorin generated light decreased further than that observed in the absence of cyclopiazonic acid. Cyclopiazonic acid also prevented the increase in apoaequorin generated light upon washout of phenylephrine, consistent with its inhibition of sarcoplasmic reticulum refilling. These results suggest that light production from targeted apoaequorin, delivered by a replication deficient adenovirus, is a valid measure of changes in [Ca2+]sr in the intact arterial wall. There appeared to be a correlation between Ca2+ release and contraction in these lightly loaded arteries.
Rembold
C M
CM
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Kendall
J M
JM
Campbell
A K
AK
D000256:Adenoviridae / Q000235:genetics*; D000331:Aequorin / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001059:Apoproteins / Q000235:genetics / Q000378:metabolism*; D001158:Arteries / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism; D018390:Gene Targeting; D005822:Genetic Vectors; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000378:metabolism*; D013623:Tail
D001059:Apoproteins; D002135:Calcium-Binding Proteins; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; C060014:apoaequorin; D000331:Aequorin; D002118:Calcium